ARCHIVE: World Bio Markets - AI and Machine Learning - The Silver Bullet we Must Not Dodge
press clippingsvideoARCHIVEperriman
ARCHIVE: World Bio Markets - AI and Machine Learning - The Silver Bullet we Must Not DodgeJuly 2, 2025
Dr. Paul Opgenorth
press releaseinvestornutraceuticalsmedicinescienceARCHIVE
ARCHIVE: eXoZymes selected as core industry partner in $9M NSF-funded initiative to advance modular cell-free biomanufacturingJune 26, 2025
Chris Marlett, MDB Capital
investorpress clippingsvideoARCHIVE
ARCHIVE: Slack Capital interview: Chris Marlett, Chairman of the BoardMay 22, 2025
ARCHIVE: Slack Capital interview: Damien Perriman, CCO
investorpress clippingsvideoARCHIVEperriman
ARCHIVE: Slack Capital interview: Damien Perriman, CCOMay 20, 2025
Michael Heltzen & Erum Azeez Khan
heltzenpress releaseinvestorpress clippingsvideoARCHIVEpodcast
ARCHIVE: Podcast: eXoZymes highlights scalable biomanufacturing platform and first spinout, NCTx, on 'Grow Everything'May 16, 2025
Tyler Korman
investorpress clippingsvideoARCHIVEkorman
ARCHIVE: Slack Capital interview: Tyler Korman, VP of ResearchMay 15, 2025
ARCHIVE: Transcript: eXoZymes 1st quarter 2025 and NCTx subsidiary update
investorARCHIVE
ARCHIVE: Transcript: eXoZymes 1st quarter 2025 and NCTx subsidiary updateMay 14, 2025
ARCHIVE: Slack Capital: EXOZ investment report and CEO interview
heltzeninvestorpress clippingsvideoARCHIVE
ARCHIVE: Slack Capital: EXOZ investment report and CEO interviewMay 13, 2025
ARCHIVE: eXoZymes provides first quarter 2025 and NCTx subsidiary update at 5PM EST today
press releaseinvestorARCHIVE
ARCHIVE: eXoZymes provides first quarter 2025 and NCTx subsidiary update at 5PM EST todayMay 12, 2025
ARCHIVE: eXoZymes to host first quarter 2025 and subsidiary NCTx update on Monday May 12, 2025, at 5PM EST
press releaseinvestorARCHIVE
ARCHIVE: eXoZymes to host first quarter 2025 and subsidiary NCTx update on Monday May 12, 2025, at 5PM ESTMay 7, 2025
Previous page
Page 10 of 16
Next page